Proposal Brief
Industry
Pharmaceuticals
Sub Industry
Pharmaceutical Manufacturing (Bulk Drug & API)
Deal Size
INR 2 - 20 Cr
Preferred Location
India
Region
Across India
Looking to acquire
B2B, B2C, B2B2C, B2G Manufacturing businesses (Own Brand & Contract Manufacturing)
Open for Distressed Assets
No
Target Requirement
The buyer is seeking organic and inorganic growth opportunities within the API (Active Pharmaceutical Ingredient) manufacturing sector, with a dedicated budget of ₹20–30 Crores for strategic investments or acquisitions. The buyer is specifically targeting post-revenue B2B ventures that operate WHO-GMP certified facilities and possess a strong portfolio of niche molecules or high-value intermediates.
By integrating these manufacturing capabilities with our established global logistics network and expertise in cold-chain and hazardous cargo handling, we aim to create a vertically integrated pharmaceutical supply chain that drives operational excellence and expands our footprint in the global healthcare market.
